Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026 and Aug 2026.
- Largest single sale: $2.2M (68,685 shares) of Teva Pharmaceutical Industries Ltd on Mar 3, 2026. Filing
- Last sale before this period: Aug 1, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd (TEVA) | Executive Vice President, Global R&D and Chief Medical Officer | Aug 3, 2022 | Aug 5, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 3, 2026, Teva Pharmaceutical Industries Ltd: sold 25,578 shares for $892K, under a disclosed plan; 52,744 shares vested. 1 filing: 1
- Mar 5, 2026, Teva Pharmaceutical Industries Ltd: sold 9,533 shares for $302K, under a disclosed plan; 19,654 shares vested. 1 filing: 1
- Mar 4, 2026, Teva Pharmaceutical Industries Ltd: sold 11,277 shares for $366K, under a disclosed plan; 23,251 shares vested. 1 filing: 1
- Mar 3, 2026, Teva Pharmaceutical Industries Ltd: sold 80,762 shares for $2.6M, under a disclosed plan; 166,378 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.